top of page
Biosciences
Offspring
Insights & Updates
Four Reasons Antibody Programs Fail Before They Reach Patients
The most successful translational strategies increasingly focus on generating human-relevant evidence earlier, when development teams still have the opportunity to refine candidate selection, optimize trial design, and reduce uncertainty before major investments are made.
Featured
Search
Four Reasons Antibody Programs Fail Before They Reach Patients
The most successful translational strategies increasingly focus on generating human-relevant evidence earlier, when development teams still have the opportunity to refine candidate selection, optimize trial design, and reduce uncertainty before major investments are made.
evadanielson55
Jul 144 min read
Every Failed Program Looked Promising Once
Drug discovery has always involved making high-stakes decisions before all the answers are available. The challenge for R&D leadership is determining which uncertainties are acceptable, and which are systemic liabilities capable of derailing an entire program at the clinical threshold.
evadanielson55
Jun 154 min read
Beyond the Checklist: Strategic TMAs for Definitive Tissue Cross-Reactivity
Executed strategically, using a specifically curated Tissue Microarray (TMA), TCR studies provide a rich dataset that provides "Deep Insights" into novel therapeutic antibodies, their comparative performance, and their associated risk in human patient trials.
evadanielson55
May 264 min read
bottom of page